Dr. Li on ISC26 LB 32-LAIS trial overview

Shuya Li, M.D., director of the Clinical Trial Center and head of the Phase I Clinical Research Unit at Beijing Tiantan Hospital in Beijing.

I have read the AHA/ASA Multimedia Materials Usage Policy and agree to the terms of use

This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.

CLOSE PROCEED